AtriCure, Inc. (ATRC)
NASDAQ: ATRC · IEX Real-Time Price · USD
24.17
-0.50 (-2.03%)
At close: Jul 19, 2024, 4:00 PM
24.08
-0.09 (-0.37%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

AtriCure Revenue

AtriCure had revenue of $414.60M in the twelve months ending March 31, 2024, with 18.70% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $108.85M with 16.43% year-over-year growth. In the year 2023, AtriCure had annual revenue of $399.25M with 20.84% growth.

Revenue (ttm)
$414.60M
Revenue Growth
+18.70%
P/S Ratio
2.82
Revenue / Employee
$394,859
Employees
1,050
Market Cap
1.17B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023399.25M68.87M20.84%
Dec 31, 2022330.38M56.05M20.43%
Dec 31, 2021274.33M67.80M32.83%
Dec 31, 2020206.53M-24.28M-10.52%
Dec 31, 2019230.81M29.18M14.47%
Dec 31, 2018201.63M26.91M15.40%
Dec 31, 2017174.72M19.61M12.64%
Dec 31, 2016155.11M25.35M19.54%
Dec 31, 2015129.76M22.30M20.75%
Dec 31, 2014107.45M25.57M31.22%
Dec 31, 201381.89M11.64M16.57%
Dec 31, 201270.25M5.85M9.08%
Dec 31, 201164.40M5.40M9.14%
Dec 31, 201059.01M4.47M8.20%
Dec 31, 200954.53M-723.47K-1.31%
Dec 31, 200855.26M6.95M14.38%
Dec 31, 200748.31M10.07M26.32%
Dec 31, 200638.24M7.29M23.54%
Dec 31, 200530.96M11.80M61.60%
Dec 31, 200419.16M9.36M95.63%
Dec 31, 20039.79M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Owens & Minor 10.42B
Omnicell 1.10B
Artivion 368.21M
Maravai LifeSciences Holdings 274.10M
Xencor 162.18M
Establishment Labs Holdings 155.79M
Prothena Corporation 89.25M
Ocular Therapeutix 59.84M
Revenue Rankings